Literature DB >> 11301399

Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.

K Kramer1, B Kushner, G Heller, N K Cheung.   

Abstract

BACKGROUND: The central nervous system (CNS) can be a sanctuary site for cancer cells, because the blood-brain barrier impedes penetration of most chemotherapeutic agents. The authors hypothesized that, with improved survival from childhood metastatic neuroblastoma (NB), the incidence of CNS (intraparenchymal and leptomeningeal) spread may increase. They undertook this study to assess the frequency of CNS NB, to analyze risk factors and treatment options, and to review the literature.
METHODS: The authors retrospectively analyzed all patients with metastatic NB who were treated on protocols N4, N5, N6, and N7 from 1980 to 1999 at Memorial Sloan-Kettering Cancer Center (MSKCC), during which time there was an increase in the overall survival rate.
RESULTS: Two hundred fifty-one patients with Stage 4 NB (Group 251) were studied, of which 127 (Group 127) were newly diagnosed patients who were treated initially at MSKCC. None had CNS NB at the time of diagnosis. Eleven patients developed documented CNS disease; 8 of these 11 recurrences were isolated in the CNS. For Group 127, the overall incidence rate of CNS NB was 6.3%, with an increase in incidence from N4-N5 to N6-N7 of from 1.7% to 11.7%. Seven patients had isolated CNS disease recurrences. Only lumbar punctures (LP) performed near the time of diagnosis in patients with known bone marrow involvement were associated with subsequent development of CNS disease. For the entire group of 251 patients, lumbar puncture at the time of diagnosis and elevated serum lactic dehydrogenase levels were prognostic. Among the larger series reported in the literature, CNS involvement from metastatic lesions was rare at the time of diagnosis and remained an uncommon complication.
CONCLUSIONS: The incidence of CNS NB may be increasing. Because it is the sole site of disease recurrence in 64% of patients, the CNS may represent a sanctuary site for NB. CNS NB is associated with diagnostic lumbar punctures in patients with known bone marrow disease, raising the possibility that circulating or epidural microscopic tumor cells may seed the craniospinal axis. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11301399

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

Review 1.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Neurological Complications of Pediatric Cancer.

Authors:  Elizabeth C Neil; Sharyu Hanmantgad; Yasmin Khakoo
Journal:  J Child Neurol       Date:  2015-12-29       Impact factor: 1.987

3.  Diagnostic identification of malignant cells in the cerebrospinal fluid by tumor-specific qRT-PCR.

Authors:  Cristina Rosanda; Claudio Gambini; Barbara Carlini; Massimo Conte; Bruno De Bernardi; Alberto Garaventa; Maria Valeria Corrias
Journal:  Clin Exp Metastasis       Date:  2006-09-22       Impact factor: 5.150

Review 4.  [Cranial nerves - spectrum of inflammatory and tumorous changes].

Authors:  S F Nemec; G Kasprian; U Nemec; C Czerny
Journal:  Radiologe       Date:  2009-07       Impact factor: 0.635

5.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

6.  Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.

Authors:  Neeta Pandit-Taskar; Pat B Zanzonico; Kim Kramer; Milan Grkovski; Edward K Fung; Weiji Shi; Zhigang Zhang; Serge K Lyashchenko; Alex M Fung; Keith S Pentlow; Jorge A Carrasquillo; Jason S Lewis; Steven M Larson; Nai-Kong V Cheung; John L Humm
Journal:  J Nucl Med       Date:  2019-08-12       Impact factor: 10.057

7.  Intracranial metastasis of neuroblastoma: in two different areas at the same time.

Authors:  Dogan Kose; Pinar Karabagli; Güler Yavas; Hakan Karabagli; Yavuz Koksal
Journal:  Childs Nerv Syst       Date:  2013-06-21       Impact factor: 1.475

8.  Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.

Authors:  Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

9.  Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.

Authors:  Dana-Lynn T Koomoa; Lisette P Yco; Tamas Borsics; Christopher J Wallick; André S Bachmann
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  Neurological complications of neuroblastic tumors: experience of a single center.

Authors:  G Burca Aydin; M Tezer Kutluk; Munevver Buyukpamukcu; Canan Akyuz; Bilgehan Yalcin; Ali Varan
Journal:  Childs Nerv Syst       Date:  2009-08-28       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.